Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) EBT Margin (2016 - 2025)

Bio-Techne (TECH) has 17 years of EBT Margin data on record, last reported at 17.16% in Q4 2025.

  • For Q4 2025, EBT Margin rose 273.0% year-over-year to 17.16%; the TTM value through Dec 2025 reached 9.39%, up 848.0%, while the annual FY2025 figure was 8.07%, 713.0% up from the prior year.
  • EBT Margin reached 17.16% in Q4 2025 per TECH's latest filing, up from 16.75% in the prior quarter.
  • Across five years, EBT Margin topped out at 5185.8% in Q3 2022 and bottomed at 43.5% in Q2 2024.
  • Average EBT Margin over 5 years is 271.42%, with a median of 17.53% recorded in 2025.
  • Peak YoY movement for EBT Margin: soared 515965bps in 2022, then plummeted -516790bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 32.0% in 2021, then fell by -24bps to 24.46% in 2022, then crashed by -50bps to 12.25% in 2023, then grew by 18bps to 14.43% in 2024, then increased by 19bps to 17.16% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 17.16% in Q4 2025, 16.75% in Q3 2025, and 7.21% in Q2 2025.